However, it is crucial to highlight that the CD4+ T cell count, used as an indicator of immune function and the risk of developing opportunistic infections in HIV patients, is not a reliable criterion for the prophylaxis of PJP in non-HIV patients [4, 10]. The gene discussed is CD4; the disease is pneumocystosis.